Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CLDI US Equity

Calidi Biotherapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1855485 · FY ends Dec 31
$1.34
+0.00 (+0.00%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ARMISTICE CAPITAL, LLCsec.gov ↗
2026-08-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-318-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-07-318-K 3.03Material modification to rights of security holderssec.gov ↗
2026-07-168-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-07-168-K 1.02Termination of a material definitive agreementsec.gov ↗
2026-07-168-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-16

Every row is a filed document, checked against its EDGAR index.